Bayer MaterialScience has launched a range of innovative biomaterials for medical devices under the new brand name Baymedix. This includes Baymedix CL lubricious coatings, the drug-eluting Baymedix CD coatings, and hydrophilic Baymedix CH coatings, which are characterized by very high mechanical strength and particular hemocompatibility. It also encompasses Baymedix FG foams for wound dressings and Baymedix AT topical tissue adhesives that are currently in development. These products can be used as an alternative to stitching materials for medical wound closure. While Bayer MaterialScience has a decades-long history of supplying medical-grade thermoplastic resins such as Makrolon polycarbonate and Texin thermoplastic polyurethane, the Baymedix name refers to its new biomaterials segment. The company said it intends to aggressively grow this coatings-related medical business in the next few years.